Literature DB >> 2491206

HTLV-1 associated myelopathy in an HTLV-1 and HBV double carrier family: report of a case and the mode of vertical transmission of both viruses.

F Nakamura1, H Kajihara, M Nakamura, H Sasaki, T Kumamoto, K Okada.   

Abstract

Osame et al. first described human T cell lymphotropic virus type 1 (HTLV-1) associated myelopathy (HAM) as a new clinical entity in 1986. A 23 year old female diagnosed as having HAM whose family had a high frequency of double virus infection with HTLV-1 and hepatitis B virus (HBV) gave reason to suspect mother-to-child transmission of both viruses. No clear coincidence in the mode of transmission of HTLV-1 and HBV was found. It is presumed that the mechanism of infection with HTLV-1 and HBV differ slightly.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2491206     DOI： 10.1111/j.1440-1746.1989.tb00850.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN： 0815-9319            Impact factor:   4.029


  5 in total

1.  Coactivator-associated arginine methyltransferase 1 enhances transcriptional activity of the human T-cell lymphotropic virus type 1 long terminal repeat through direct interaction with Tax.

Authors:  Soo-Jin Jeong; Hanxin Lu; Won-Kyung Cho; Hyeon Ung Park; Cynthia Pise-Masison; John N Brady
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

2.  Palmitoylation and p8-mediated human T-cell leukemia virus type 1 transmission.

Authors:  Dustin Edwards; Risaku Fukumoto; Maria Fernanda de Castro-Amarante; Luiz Carlos Junior Alcantara; Bernardo Galvão-Castro; Robyn Washington Parks; Cynthia Pise-Masison; Genoveffa Franchini
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

3.  Inhibition of methyltransferases results in induction of g2/m checkpoint and programmed cell death in human T-lymphotropic virus type 1-transformed cells.

Authors:  Arindam Dasgupta; Kyung-Jin Jung; Soo-Jin Jeong; John N Brady
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

4.  Modulation of the Brd4/P-TEFb interaction by the human T-lymphotropic virus type 1 tax protein.

Authors:  Won-Kyung Cho; Meisheng Zhou; Moon Kyoo Jang; Keven Huang; Soo-Jin Jeong; Keiko Ozato; John N Brady
Journal:  J Virol       Date:  2007-08-08       Impact factor: 5.103

5.  Inhibition of geranylgeranyl transferase-I decreases cell viability of HTLV-1-transformed cells.

Authors:  Dustin C Edwards; Katherine M McKinnon; Claudio Fenizia; Kyung-Jin Jung; John N Brady; Cynthia A Pise-Masison
Journal:  Viruses       Date:  2011-10-10       Impact factor: 5.048
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.